---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-002893"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2022-02-01T23:59:59+00:00"
generated_at: "2026-06-27T13:10:28.586736+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Indaptus Therapeutics enters employment agreement with CFO Nir Sassi; base salary $345,000

## Summary
- Annual base salary of $345,000 with annual review; eligible for target bonus up to 40% of base salary.
- Prior consulting agreement terminated; separately agreed to pay $195,728 termination payment to Mr. Sassi.
- Severance of 12 months base salary if terminated without cause or resigns for good reason.
- Change-in-control severance: 12 months base plus target bonus, plus accelerated equity vesting.

## SEC filing metadata
- accession: 0001493152-22-002893
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2022-02-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000149315222002893/0001493152-22-002893-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000149315222002893/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-002893
- JSON: https://secwatch.observer/filing/0001493152-22-002893.json
- Plain text: https://secwatch.observer/filing/0001493152-22-002893.txt

## Key facts
- Executive change
  Nir Sassi was appointed as Chief Financial Officer at Indaptus Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On February 1, 2022, Intec Pharma Ltd. (“Intec”), a wholly owned subsidiary of Indaptus Therapeutics, Inc. (the “Company”) entered into an employment agreement (the “Employment Agreement”) with Nir Sassi, the Company’s Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857044/000149315222002893/0001493152-22-002893-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.